Delivery Order SPE2DB20D2014-SPE2DB24FB30Z
Award Date 3/12/24
Potential Completion Date 3/13/24
Potential Value $13K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $18,406.13, is for the delivery of ELIQUIS 5 MG TABLET 60S, a pharmaceutical product, to support military and veterans' healthcare programs. The IDC with the DLA is valued at up to $999,999,999.00 and runs through November 2026, providing a comprehensive...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $12,252.77 for the supply of ELIQUIS 5 MG TABLET 60S. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of April 28, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued up to $999,999,999.00 and running through November...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $43,346.80 for the delivery of ELIQUIS 5 MG TABLET 60S. The contract is issued by the Defense Logistics Agency (DLA) Troop Support Medical, a division of the Department of Defense. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $4,531.11 for the supply of ELIQUIS 5 MG TABLET 60S. The award was made by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- The information provided describes a federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract, valued at $18,356.80, is a delivery order awarded by the Defense Logistics Agency (DLA) for the supply of ELIQUIS 5 MG TABLET 60S, a medication. This award is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $12,547.61 for the pharmaceutical product ELIQUIS 5 MG TABLET 60S. The award was made by the Defense Logistics Agency (DLA), a defense agency that provides logistics, acquisition, and technical services to the U.S. military. The contract has a firm fixed price and an ultimate completion date of March 2, 2023. It is not designated as a set-aside contract. Amerisourcebergen Drug...
- This federal contract award to Amerisourcebergen Drug Corp., a subsidiary of Cencora, Inc., is a Delivery Order valued at $7,261.79 for the supply of ELIQUIS 5 MG TABLET 60S. The contract was awarded by the Defense Logistics Agency (DLA), which is a component of the Department of Defense (DoD) responsible for providing supplies and services to the U.S. military. The contract has an ultimate completion date of March 9, 2023 and is a Firm Fixed Price arrangement. There is no set-aside designation,...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order under a $999,999,999 Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The order is for the supply of ELIQUIS 5 MG TABLET 60S, a pharmaceutical product, with a ceiling value of $21,413.75. The contract has a performance period through December 1, 2023 and is structured as a firm fixed price arrangement. The award was made through full...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order (SPE2DB24FKZB2) under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $3,835.95, is for the delivery of ELIQUIS 5 MG TABLET 60S, a pharmaceutical product, to support federal healthcare programs. The IDC has a total potential value of $999,999,999.00 and runs through November 2026, enabling the DLA to...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $5,445.48 for the supply of ELIQUIS 5 MG TABLET 60S medication. The award, issued by the Defense Logistics Agency (DLA), is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB24FB30ZDelivery Order
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $13,336.46 for the supply of ELIQUIS 5 MG TABLET 60S. The award was made by the Defense Logistics Agency (DLA) under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00, which runs through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract was awarded on a full and open competition basis without any set-aside designation.
Generated 5/14/25, 10:40 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.3k | 3/12/24 |